GlassScriptPhysician profile
Soon Y Jung
NPI 1528407392
$57,667.24
in general payments reported to CMS, 2019-2025
48 companies · $1,374 in 2025
The $1,374 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $4,448 · 2021: $16K · 2022: $11K · 2023: $6,377 · 2024: $2,235 · 2025: $1,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,647 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,700 · Consulting Fee: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,647.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,700.00 |
| Consulting Fee | $637.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $40,850.52 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Abbott Laboratories | $4,156.25 | 2021-2025 | Eterna, Proclaim, Octrode |
| Medtronic USA, INC. | $3,806.30 | 2019-2020 | |
| Nevro Corp. | $1,415.16 | 2021-2024 | Senza |
| Medtronic, INC. | $1,095.35 | 2021 | |
| Collegium Pharmaceutical, INC. | $748.14 | 2021-2025 | Belbuca, Xtampza, Elyxyb - Celecoxib |
| Vertos Medical, INC. | $637.55 | 2021-2024 | Mild Device Kit |
| Abbvie INC. | $575.05 | 2021-2025 | |
| Vertiflex, INC. | $501.96 | 2019 | |
| Stryker Corporation | $321.67 | 2021-2025 | Mild Device Kit, Cascadia Interbody System |
| Relievant Medsystems, INC. | $320.68 | 2021-2022 | |
| Painteq LLC | $307.03 | 2023-2024 | Painteq |
| Globus Medical, INC. | $286.20 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $250.87 | 2021-2023 | Ztlido |
| Foundation Fusion Solutions, LLC | $246.62 | 2021-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $237.81 | 2022-2023 | Nalu Neurostimulation System |
| Ibsa Pharma INC. | $219.66 | 2023-2024 | Tirosint, Licart, Tirosint |
| Lilly USA, LLC | $182.31 | 2021-2024 | Emgality, Reyvow |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.06 | 2021-2024 | Relistor |
| Forte Bio-Pharma LLC | $127.13 | 2021-2022 | |
| Valinor Pharma, LLC | $107.63 | 2023-2025 | Movantik |
| Tersera Therapeutics LLC | $96.44 | 2019-2021 | |
| Neuronetics, INC. | $79.66 | 2020 | |
| Averitas Pharma INC. | $78.96 | 2023-2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $78.54 | 2024-2025 | |
| Pfizer INC. | $76.71 | 2019-2023 | |
| Stimwave Technologies Incorporated | $75.39 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $69.05 | 2022-2023 | Seglentis |
| Teva Pharmaceuticals USA, INC. | $66.51 | 2023-2024 | Austedo Xr, Austedo |
| Fidia Pharma USA INC. | $57.10 | 2022-2023 | Hyalgan, Triluron |
| Amneal Pharmaceuticals LLC | $49.78 | 2023 | Lyvispah |
| Curonix LLC | $37.91 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mml US, INC. | $36.62 | 2023 | Reactiv8 |
| Axsome Therapeutics, INC. | $31.99 | 2023 | Sunosi |
| Si-Bone, INC. | $31.93 | 2024 | |
| Neurocrine Biosciences, INC. | $31.35 | 2024 | Ingrezza |
| Grt US Holding, INC. | $30.60 | 2021 | |
| Biodelivery Sciences International, INC. | $27.94 | 2020 | |
| Lundbeck LLC | $23.52 | 2025 | Vyepti |
| Appliedvr INC | $18.26 | 2025 | Relievrx |
| Pacira Pharmaceuticals Incorporated | $17.64 | 2024 | Iovera, Zilretta |
| Currax Pharmaceuticals LLC | $17.48 | 2022 | |
| Amgen INC. | $16.13 | 2021 | |
| Azurity Pharmaceuticals, INC. | $15.89 | 2024 | Horizant |
| Novus Surgical Consultants | $14.72 | 2025 | |
| Trevena, INC. | $13.19 | 2021 | |
| Horizon Therapeutics Plc | $12.90 | 2022 | |
| Assertio Therapeutics, INC. | $12.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soon Jung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.